Explore the growing role of flow cytometry in supporting humoral immunogenicity testing for cell and gene therapies.

This webinar examines the complexities of evaluating immune responses to advanced therapies and highlights how flow cytometry is being applied to anti-drug antibody (ADA) and neutralizing antibody (NAb) assays. Learn key considerations for assay development, validation, and the generation of reliable immunogenicity data to support clinical development.

In this webinar, you'll learn:

• The challenges of assessing humoral immunogenicity for cell and gene therapies
• How flow cytometry supports ADA and NAb assay development and testing
• Key considerations for developing and validating flow cytometry-based immunogenicity assays
• Best practices for generating robust, reliable immune response data in clinical studies

As cell and gene therapies continue to evolve, accurate immunogenicity assessments are essential for demonstrating safety and efficacy. Discover how flow cytometry is helping advance humoral immune response testing and supporting successful clinical development.